title: Infliximab induced endophthalmitis in a patient of fistulizing Crohn's disease.
authors.forename: Rashi
authors.initials: R
authors.lastname: Kochhar
authors.forename: Vishali
authors.initials: V
authors.lastname: Gupta
authors.forename: Usha
authors.initials: U
authors.lastname: Dutta
authors.forename: Kartar
authors.initials: K
authors.lastname: Singh
authors.forename: Rakesh
authors.initials: R
authors.lastname: Kochhar
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D003113:Colonoscopy; D003424:Crohn Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D009877:Endophthalmitis / Q000188:drug therapy / Q000382:microbiology*; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D006801:Humans; D000069285:Infliximab; D011008:Pneumococcal Infections / Q000188:drug therapy / Q000382:microbiology*; D012006:Rectovaginal Fistula / Q000188:drug therapy*; D014821:Vitrectomy; D014822:Vitreous Body / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab